A Clinical Trial of Multiple Doses of GR2301 Injection in Healthy Adult Trial Participants in China.

NCT07647224 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Dose
Healthy Adult Participants

Interventions

DRUG: GR2301 injection

Sponsor

Genrix (Shanghai) Biopharmaceutical Co., Ltd.